Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2130806rdf:typepubmed:Citationlld:pubmed
pubmed-article:2130806lifeskim:mentionsumls-concept:C2359945lld:lifeskim
pubmed-article:2130806lifeskim:mentionsumls-concept:C0039194lld:lifeskim
pubmed-article:2130806lifeskim:mentionsumls-concept:C0019630lld:lifeskim
pubmed-article:2130806lifeskim:mentionsumls-concept:C0019754lld:lifeskim
pubmed-article:2130806lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:2130806lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:2130806pubmed:issue5-6lld:pubmed
pubmed-article:2130806pubmed:dateCreated1991-11-6lld:pubmed
pubmed-article:2130806pubmed:abstractTextThe influence of immunosuppressive drugs on class II (HLA-D) antigen synthesis and expression by monocytes and B and T cells was studied. The constitutive HLA-D expression on monocytes and malignant B cells was resistant, while the acquisition of those markers by stimulated T cells very sensitive to immunosuppression. Active derivative of cyclophosphamide (4HCy) and cyclosporine proved to be most efficacious inhibitors of class II antigens.lld:pubmed
pubmed-article:2130806pubmed:languageenglld:pubmed
pubmed-article:2130806pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2130806pubmed:citationSubsetIMlld:pubmed
pubmed-article:2130806pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2130806pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2130806pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2130806pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2130806pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2130806pubmed:statusMEDLINElld:pubmed
pubmed-article:2130806pubmed:issn0004-069Xlld:pubmed
pubmed-article:2130806pubmed:authorpubmed-author:GórskiAAlld:pubmed
pubmed-article:2130806pubmed:authorpubmed-author:Modli?skaMMlld:pubmed
pubmed-article:2130806pubmed:authorpubmed-author:PlutaAAlld:pubmed
pubmed-article:2130806pubmed:authorpubmed-author:NowaczykMMlld:pubmed
pubmed-article:2130806pubmed:authorpubmed-author:BukowskiRRlld:pubmed
pubmed-article:2130806pubmed:issnTypePrintlld:pubmed
pubmed-article:2130806pubmed:volume38lld:pubmed
pubmed-article:2130806pubmed:ownerNLMlld:pubmed
pubmed-article:2130806pubmed:authorsCompleteYlld:pubmed
pubmed-article:2130806pubmed:pagination415-9lld:pubmed
pubmed-article:2130806pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2130806pubmed:meshHeadingpubmed-meshheading:2130806-...lld:pubmed
pubmed-article:2130806pubmed:meshHeadingpubmed-meshheading:2130806-...lld:pubmed
pubmed-article:2130806pubmed:meshHeadingpubmed-meshheading:2130806-...lld:pubmed
pubmed-article:2130806pubmed:meshHeadingpubmed-meshheading:2130806-...lld:pubmed
pubmed-article:2130806pubmed:meshHeadingpubmed-meshheading:2130806-...lld:pubmed
pubmed-article:2130806pubmed:meshHeadingpubmed-meshheading:2130806-...lld:pubmed
pubmed-article:2130806pubmed:meshHeadingpubmed-meshheading:2130806-...lld:pubmed
pubmed-article:2130806pubmed:meshHeadingpubmed-meshheading:2130806-...lld:pubmed
pubmed-article:2130806pubmed:year1990lld:pubmed
pubmed-article:2130806pubmed:articleTitleImmunosuppressive drugs inhibit class II antigen (HLA-D) synthesis by B and T lymphocytes.lld:pubmed
pubmed-article:2130806pubmed:affiliationDepartment of Immunology, Transplantation Institute, Warsaw.lld:pubmed
pubmed-article:2130806pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2130806pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:2130806pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed